Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.

    Pancreatic Cancer Patients in the Phase 2 OCLURANDOM Trial See a Twelve Month Progression-Free Survival of 80 Percent

    Medscape Medical News reports that results have been received from the OCCLURANDOM Phase 2 trial which is the first randomized trial investigating the antitumor effect of the peptide receptor radionuclide…

    Continue Reading Pancreatic Cancer Patients in the Phase 2 OCLURANDOM Trial See a Twelve Month Progression-Free Survival of 80 Percent
    Two Studies Lead to Possible Therapeutic Approach for Neurodegenerative Diseases
    source: pixabay.com

    Two Studies Lead to Possible Therapeutic Approach for Neurodegenerative Diseases

      The loss of axons (nervous system wiring) has been responsible for various neurodegenerative diseases such as peripheral neuropathies, Parkinson’s disease, glaucoma, and amyotrophic lateral sclerosis (ALS). According to a…

    Continue Reading Two Studies Lead to Possible Therapeutic Approach for Neurodegenerative Diseases
    Results of a Three-Year Study Support AUSTEDO to Treat Chorea Related to Huntington’s Disease
    source: unsplash.com

    Results of a Three-Year Study Support AUSTEDO to Treat Chorea Related to Huntington’s Disease

    According to the National Institute of Neurological Disorders and Stroke, chorea is defined as involuntary movements that are caused by a neurological disorder. It is one of a group of…

    Continue Reading Results of a Three-Year Study Support AUSTEDO to Treat Chorea Related to Huntington’s Disease

    Will This Novel Drug That Utilizes AI Succeed in Having an Impact on ALS When so Many Others Have Failed?

    Verge Genomics, based in San Francisco is one of a series of biotechs that have entered into a new era using AI in drug discovery. The company is backed by…

    Continue Reading Will This Novel Drug That Utilizes AI Succeed in Having an Impact on ALS When so Many Others Have Failed?

    Treatment for Adult Patients with Chronic Immune Thrombocytopenia (ITP) is Now Available in the UK

    Fostamatinib is a spleen tyrosine kinase (SYK) inhibitor recommended to treat ITP patients who have been unable to receive a sufficient response from other medications. TAVLESSE® (fostamatinib), developed by Grifols…

    Continue Reading Treatment for Adult Patients with Chronic Immune Thrombocytopenia (ITP) is Now Available in the UK

    Study: Diffuse Large B-Cell Lymphoma Patients May Benefit from Involvement in Decision Making

    Due to varied periods of decline among patients, previous research indicates that it is difficult to develop treatment options for patients who have relapsed DLBCL. This holds true especially when…

    Continue Reading Study: Diffuse Large B-Cell Lymphoma Patients May Benefit from Involvement in Decision Making